PAPER Mondal A, Bose D, Saha P, Sarkar S, Seth R, Kimono D, Albadrani M, Nagarkatti M, Nagarkatti P, Chatterjee S
SEARCH RESULTS
16619 RESULTS
"Brain's Resilience and Intelligence Networks (B.R.A.I.N.)" Seminar Series: Meditation as a mental training to promote healthy aging and prevent neurodegenerative diseases: the Medit-Ageing model
CONFERENCE 2020-07-16 00:00:00-2020-07-16 00:00:00 Online Meeting 16 July 2020 Organizer: Michael Ewers, Ph.D., Ludwig Maximilian University, Munich & German Center for Neurodegenerative Diseases (DZNE) Munich. Speaker: Gaël Chételat, PhD & Antoine Lutz, PhD, INSERM, France Meeting time: 11 AM ...
Tofersen
THERAPEUTICS Biogen IONIS Pharmaceuticals BIIB067 Ionis-SOD1Rx ASO1 DNA/RNA-based Other In January 2016, Biogen and Ionis began a Phase 1/2 safety trial in SOD1-ALS. The study enrolled 84 people who received single or multiple ascending doses by intrathecal injection ...
Marcio Silva
Brazil
Director, Center for Brain Health & Associate Professor or Professor of IMSD
JOB 2020-07-10 Employer Florida Atlantic University Contact All applicants must apply electronically to the currently posted position (Director, Center for Brain Health & Associate Professor or Professor of Integrated Medical Science) on the Office of Human ...
Susanne Fabre
Stockholm, Sweden
PAPER Leon M, Sawmiller D, Shytle RD, Tan J
Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer's Disease.
Cell Med. 2018;10:2155179017722280. Epub 2018 Jan 25 PubMed: 32634177PAPER Hardiman O, van den Berg LH
The Beginning of Genomic Therapies for ALS.
N Engl J Med. 2020 Jul 9;383(2):180-181. PubMed: 32640137PAPER Davda N, Corkill R
Biomarkers in the diagnosis and prognosis of Alzheimer's disease.
J Neurol. 2020 Aug;267(8):2475-2477. PubMed: 32638106PAPER Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, Douthwright CL, Gelevski D, Luppino SD, Blackwood M, Wightman NS, Oakley DH, Frosch MP, Flotte TR, Cudkowicz ME, Brown RH Jr
SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.
N Engl J Med. 2020 Jul 9;383(2):151-158. PubMed: 32640133PAPER Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, Trudell R, Van Damme P, Zinman L, Bennett CF, Lane R, Sandrock A, Runz H, Graham D, Houshyar H, McCampbell A, Nestorov I, Chang I, McNeill M, Fanning L, Fradette S, Ferguson TA
Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
N Engl J Med. 2020 Jul 9;383(2):109-119. PubMed: 32640130PAPER Verkhratsky A, Zorec R
Large-Scale Proteomics Highlights Glial Role in Neurodegeneration.
Cell Metab. 2020 Jul 7;32(1):11-12. PubMed: 32640242PAPER Hernández-Rodríguez M, Arciniega-Martínez IM, García-Marín ID, Correa-Basurto J, Rosales-Hernández MC
Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.
Mol Neurobiol. 2020 Sep;57(9):3979-3988. Epub 2020 Jul 7 PubMed: 32638218PAPER Henríquez G, Mendez L, Schmid AN, Guerrero ED, Collins SA, Castañeda E, Narayan M
Testing Amyloid Cross-Toxicity in the Vertebrate Brain.
ACS Omega. 2020 Jun 30;5(25):15586-15591. Epub 2020 Jun 15 PubMed: 32637834PAPER Peters ST, Fahrenkopf A, Choquette JM, Vermilyea SC, Lee MK, Vossel K
Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human α-Synuclein.
Front Neurol. 2020;11:563. Epub 2020 Jun 19 PubMed: 32636798Current Filters
- Date Range : Jul 2019 to Jul 2020 x